Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Bioparox Spray
2. Fusafungin
3. Locabiotal
1. 1393-87-9
2. Fusafungin
3. Fusafungina
4. Fusafunginum
5. Enniatin
6. (3s,9s,15s)-4,10,16-trimethyl-3,6,9,12,15,18-hexa(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone
7. Locabiotal
8. Biofusal
9. Bioparox
10. Fusaloyos
11. Bioparox Spray
12. Fusafunginum [inn-latin]
13. Fusafungina [inn-spanish]
14. Fusafungine [inn:ban:dcf]
15. Unii-65dd690w0c
16. S 314
17. Einecs 215-737-5
18. Schembl16242889
19. Dtxsid50912008
20. 65dd690w0c
21. Db08965
22. Q222424
23. (3s,9s,15s)-3,6,9,12,15,18-hexaisopropyl-4,10,16-trimethyl-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexaone
24. 4,10,16-trimethyl-3,6,9,12,15,18-hexa(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone
25. Antibiotic Obtained From Cultures Of A Fusarium Belonging To Lateritium Wr. Section, Or The Same Substance Produced By Any Other Means
| Molecular Weight | 639.8 g/mol |
|---|---|
| Molecular Formula | C33H57N3O9 |
| XLogP3 | 6.5 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 6 |
| Exact Mass | 639.40948040 g/mol |
| Monoisotopic Mass | 639.40948040 g/mol |
| Topological Polar Surface Area | 140 Ų |
| Heavy Atom Count | 45 |
| Formal Charge | 0 |
| Complexity | 952 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 3 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
R - Respiratory system
R02 - Throat preparations
R02A - Throat preparations
R02AB - Antibiotics
R02AB03 - Fusafungine
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
ABOUT THIS PAGE
89
PharmaCompass offers a list of Fusafungine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fusafungine manufacturer or Fusafungine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fusafungine manufacturer or Fusafungine supplier.
PharmaCompass also assists you with knowing the Fusafungine API Price utilized in the formulation of products. Fusafungine API Price is not always fixed or binding as the Fusafungine Price is obtained through a variety of data sources. The Fusafungine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Fusafungine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fusafungine, including repackagers and relabelers. The FDA regulates Fusafungine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fusafungine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Fusafungine supplier is an individual or a company that provides Fusafungine active pharmaceutical ingredient (API) or Fusafungine finished formulations upon request. The Fusafungine suppliers may include Fusafungine API manufacturers, exporters, distributors and traders.
Fusafungine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fusafungine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fusafungine GMP manufacturer or Fusafungine GMP API supplier for your needs.
A Fusafungine CoA (Certificate of Analysis) is a formal document that attests to Fusafungine's compliance with Fusafungine specifications and serves as a tool for batch-level quality control.
Fusafungine CoA mostly includes findings from lab analyses of a specific batch. For each Fusafungine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fusafungine may be tested according to a variety of international standards, such as European Pharmacopoeia (Fusafungine EP), Fusafungine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fusafungine USP).
